Actavis Can't Sell Generic Gralise After Depomed IP Trial Suit - McDermott Will & Emery

Actavis Can’t Sell Generic Gralise After Depomed IP Trial Suit

Overview


William Gaede, Bhanu Sadasivan, David Larson, Shane Smith and Daniel Greene were mentioned for their successful representation of Depomed in infringement litigation over a pain medication. A California U.S. District Court has unsealed its ruling in the case, which bars the infringer from producing and selling a generic version of the drug.